Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Take-Two price target raised to $200 from $190 at JPMorgan » 07:49
10/27/21
10/27
07:49
10/27/21
07:49
TTWO

Take-Two

$182.56 /

-0.38 (-0.21%)

JPMorgan analyst Alexia…

JPMorgan analyst Alexia Quadrani raised the firm's price target on Take-Two Interactive to $200 from $190 and keeps a Neutral rating on the shares. Shares of PC and console video game publishers have traded largely range-bound since hitting pre-earnings highs in early February, and this trend may persist in the near-term as investors weigh the impact of economic reopening and two additional quarters of tough comps, Quadrani tells investors in a research note. However, a "notable uptick in content" over the next six months "offers an opportunity for these stocks to break out of the doldrums," says the analyst. Quadrani rolled forward price targets in the sector to December 2022.

ShowHide Related Items >><<
TTWO Take-Two
$182.56 /

-0.38 (-0.21%)

TTWO Take-Two
$182.56 /

-0.38 (-0.21%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 BMO Capital
Take-Two downgraded to Market Perform from Outperform at BMO Capital
09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
TTWO Take-Two
$182.56 /

-0.38 (-0.21%)

TTWO Take-Two
$182.56 /

-0.38 (-0.21%)

TTWO Take-Two
$182.56 /

-0.38 (-0.21%)

TTWO Take-Two
$182.56 /

-0.38 (-0.21%)

Yesterday
On The Fly
Game On: Wedbush's Pachter says Activision earnings may surprise to upside » 12:27
10/26/21
10/26
12:27
10/26/21
12:27
TCEHY

Tencent

$65.04 /

+0.45 (+0.70%)

, MSFT

Microsoft

$310.28 /

+1.85 (+0.60%)

, SONY

Sony

$116.59 /

+1.38 (+1.20%)

, NTDOY

Nintendo

$54.15 /

-0.71 (-1.29%)

, UBSFY

Ubisoft

$10.76 /

-0.28 (-2.54%)

, TTWO

Take-Two

$182.45 /

-0.49 (-0.27%)

, EA

Electronic Arts

$142.54 /

+0.32 (+0.23%)

, ATVI

Activision Blizzard

$81.22 /

+0.01 (+0.01%)

For this week's edition…

ShowHide Related Items >><<
UBSFY Ubisoft
$10.76 /

-0.28 (-2.54%)

TTWO Take-Two
$182.45 /

-0.49 (-0.27%)

TCEHY Tencent
$65.04 /

+0.45 (+0.70%)

SONY Sony
$116.59 /

+1.38 (+1.20%)

NTDOY Nintendo
$54.15 /

-0.71 (-1.29%)

MSFT Microsoft
$310.28 /

+1.85 (+0.60%)

EA Electronic Arts
$142.54 /

+0.32 (+0.23%)

ATVI Activision Blizzard
$81.22 /

+0.01 (+0.01%)

TCEHY Tencent
$65.04 /

+0.45 (+0.70%)

10/11/21 Mizuho
Tencent price target lowered to HK$510 from HK$530 at Mizuho
09/24/21 Morgan Stanley
Sohu completion of Sogou deal positive in unlocking value, says Morgan Stanley
09/13/21 Loop Capital
Tencent downgraded to Hold from Buy at Loop Capital
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
MSFT Microsoft
$310.28 /

+1.85 (+0.60%)

08:41 Today Credit Suisse
Microsoft price target raised to $340 from $320 at Credit Suisse
08:33 Today Morgan Stanley
Microsoft price target raised to $364 from $331 at Morgan Stanley
08:24 Today Evercore ISI
Microsoft price target raised to $370 from $325 at Evercore ISI
08:04 Today Stifel
Microsoft price target raised to $380 from $325 at Stifel
SONY Sony
$116.59 /

+1.38 (+1.20%)

09/27/21 Cowen
Sony initiated with an Outperform at Cowen
07/27/21 Morgan Stanley
Sony upgraded to Overweight at Morgan Stanley on animation business growth
07/27/21 Morgan Stanley
Sony upgraded to Overweight from Equal Weight at Morgan Stanley
NTDOY Nintendo
$54.15 /

-0.71 (-1.29%)

10/01/21 DZ Bank
Nintendo downgraded to Hold from Buy at DZ Bank
08/02/21 Wedbush
Nintendo selloff may be overdone if OLED, Pokemon deliver, says Wedbush
07/07/21 Jefferies
Jefferies downgrades Nintendo to Hold with only 7% upside seen
07/06/21 Jefferies
Nintendo downgraded to Hold from Buy at Jefferies
UBSFY Ubisoft
$10.76 /

-0.28 (-2.54%)

10/22/21 Jefferies
Ubisoft upgraded to Buy from Hold at Jefferies
10/20/21 Berenberg
Ubisoft price target lowered to EUR 72 from EUR 74 at Berenberg
10/14/21 JPMorgan
Ubisoft price target lowered to EUR 70 from EUR 84 at JPMorgan
10/14/21 JPMorgan
Ubisoft placed on 'negative Catalyst Watch' at JPMorgan
TTWO Take-Two
$182.45 /

-0.49 (-0.27%)

07:49 Today JPMorgan
Take-Two price target raised to $200 from $190 at JPMorgan
09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 BMO Capital
Take-Two downgraded to Market Perform from Outperform at BMO Capital
09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
EA Electronic Arts
$142.54 /

+0.32 (+0.23%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Raymond James
Delay of EA's Battlefield 2042 likely a 'mild negative,' says Raymond James
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
ATVI Activision Blizzard
$81.22 /

+0.01 (+0.01%)

07:49 Today JPMorgan
Activision Blizzard price target lowered to $106 from $115 at JPMorgan
10/21/21 Oppenheimer
Activision Blizzard price target lowered to $100 from $105 at Oppenheimer
09/29/21 Jefferies
Jefferies still bullish on Activision Blizzard after analyzing 72 scenarios
UBSFY Ubisoft
$10.76 /

-0.28 (-2.54%)

TTWO Take-Two
$182.45 /

-0.49 (-0.27%)

SONY Sony
$116.59 /

+1.38 (+1.20%)

NTDOY Nintendo
$54.15 /

-0.71 (-1.29%)

MSFT Microsoft
$310.28 /

+1.85 (+0.60%)

EA Electronic Arts
$142.54 /

+0.32 (+0.23%)

ATVI Activision Blizzard
$81.22 /

+0.01 (+0.01%)

UBSFY Ubisoft
$10.76 /

-0.28 (-2.54%)

TTWO Take-Two
$182.45 /

-0.49 (-0.27%)

TCEHY Tencent
$65.04 /

+0.45 (+0.70%)

SONY Sony
$116.59 /

+1.38 (+1.20%)

NTDOY Nintendo
$54.15 /

-0.71 (-1.29%)

MSFT Microsoft
$310.28 /

+1.85 (+0.60%)

EA Electronic Arts
$142.54 /

+0.32 (+0.23%)

ATVI Activision Blizzard
$81.22 /

+0.01 (+0.01%)

TTWO Take-Two
$182.45 /

-0.49 (-0.27%)

TCEHY Tencent
$65.04 /

+0.45 (+0.70%)

SONY Sony
$116.59 /

+1.38 (+1.20%)

MSFT Microsoft
$310.28 /

+1.85 (+0.60%)

EA Electronic Arts
$142.54 /

+0.32 (+0.23%)

ATVI Activision Blizzard
$81.22 /

+0.01 (+0.01%)

TTWO Take-Two
$182.45 /

-0.49 (-0.27%)

SONY Sony
$116.59 /

+1.38 (+1.20%)

MSFT Microsoft
$310.28 /

+1.85 (+0.60%)

EA Electronic Arts
$142.54 /

+0.32 (+0.23%)

ATVI Activision Blizzard
$81.22 /

+0.01 (+0.01%)

Hot Stocks
Protagonist Therapeutics earns $7.5M milestone payment from Janssen Biotech » 07:07
10/26/21
10/26
07:07
10/26/21
07:07
PTGX

Protagonist Therapeutics

$31.94 /

+0.95 (+3.07%)

, JNJ

Johnson & Johnson

$164.15 /

+0.44 (+0.27%)

Protagonist Therapeutics…

Protagonist Therapeutics (PTGX) announced that it will receive a $7.5M milestone payment from Janssen Biotech (JNJ) triggered by the completion of the clinical data collection-related Phase 1 activities for PN-235. This investigational drug candidate is one of the three IL-23 receptor antagonists that are part of Protagonist's collaboration agreement with Janssen, which provides for concurrent development of multiple oral IL-23 receptor antagonists against a broad range of indications.

ShowHide Related Items >><<
PTGX Protagonist Therapeutics
$31.94 /

+0.95 (+3.07%)

JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

PTGX Protagonist Therapeutics
$31.94 /

+0.95 (+3.07%)

10/13/21 JMP Securities
Protagonist Therapeutics price target raised to $60 from $47 at JMP Securities
10/12/21 JPMorgan
JPMorgan upgrades Protagonist after 'rapid' clinical hold removal
10/12/21 JPMorgan
Protagonist Therapeutics upgraded to Overweight from Neutral at JPMorgan
10/11/21 Jefferies
Protagonist Therapeutics price target raised to $60 from $29 at Jefferies
JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
PTGX Protagonist Therapeutics
$31.94 /

+0.95 (+3.07%)

JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

  • 16
    Jun
  • 11
    Dec
JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

PTGX Protagonist Therapeutics
$31.94 /

+0.95 (+3.07%)

JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

PTGX Protagonist Therapeutics
$31.94 /

+0.95 (+3.07%)

JNJ Johnson & Johnson
$164.15 /

+0.44 (+0.27%)

Earnings
Invesco reports Q3 adjusted EPS 77c, consensus 63c » 07:02
10/26/21
10/26
07:02
10/26/21
07:02
IVZ

Invesco

$24.73 /

-0.37 (-1.47%)

Reports Q3 adjusted…

Reports Q3 adjusted revenue $1.33B, consensus $1.14B. Reports Q3 ending AUM $1.53T. "We continue to see growth from our key capability areas, including ETFs, Fixed Income, China, Solutions, Alternatives, and Global Equities," said Marty Flanagan, president and CEO. "With this growth, we have now had five consecutive quarters of net long-term inflows for the firm."

ShowHide Related Items >><<
IVZ Invesco
$24.73 /

-0.37 (-1.47%)

IVZ Invesco
$24.73 /

-0.37 (-1.47%)

10/22/21 Evercore ISI
Invesco upgraded to In Line amid Evercore ISI rating 'reshufflng
10/22/21 Evercore ISI
Invesco upgraded to In Line from Underperform at Evercore ISI
09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
IVZ Invesco
$24.73 /

-0.37 (-1.47%)

IVZ Invesco
$24.73 /

-0.37 (-1.47%)

IVZ Invesco
$24.73 /

-0.37 (-1.47%)

IVZ Invesco
$24.73 /

-0.37 (-1.47%)

Monday
Hot Stocks
State Street names Brad Hu as Chief Risk Officer, succeeding Andrew Kuritzkes » 15:39
10/25/21
10/25
15:39
10/25/21
15:39
STT

State Street

$98.40 /

-1.11 (-1.12%)

, C

Citi

$70.85 /

-0.5 (-0.70%)

State Street (STT)…

State Street (STT) announced that it has named Brad Hu its chief risk officer, effective January 1, 2022. Hu succeeds Andrew Kuritzkes, who is retiring from State Street. Hu will join the company in November as a member of its Executive Committee for a transition period with Kuritzkes. Hu was previously the chief risk officer at Citigroup (C) for eight years.

ShowHide Related Items >><<
STT State Street
$98.40 /

-1.11 (-1.12%)

C Citi
$70.85 /

-0.5 (-0.70%)

STT State Street
$98.40 /

-1.11 (-1.12%)

10/22/21 Citi
State Street price target raised to $115 from $100 at Citi
10/20/21 UBS
State Street price target raised to $118 from $106 at UBS
10/19/21 RBC Capital
State Street price target raised to $99 from $86 at RBC Capital
10/19/21 Credit Suisse
State Street price target raised to $103 from $92 at Credit Suisse
C Citi
$70.85 /

-0.5 (-0.70%)

10/15/21 BMO Capital
Citi price target raised to $86 from $84 at BMO Capital
10/11/21 Jefferies
Citi price target raised to $87 from $81 at Jefferies
09/29/21 Oppenheimer
Morgan Stanley downgraded to Perform at Oppenheimer on valuation
07/15/21 Piper Sandler
Citi price target lowered to $91 from $95 at Piper Sandler
STT State Street
$98.40 /

-1.11 (-1.12%)

C Citi
$70.85 /

-0.5 (-0.70%)

  • 10
    Sep
STT State Street
$98.40 /

-1.11 (-1.12%)

C Citi
$70.85 /

-0.5 (-0.70%)

STT State Street
$98.40 /

-1.11 (-1.12%)

C Citi
$70.85 /

-0.5 (-0.70%)

STT State Street
$98.40 /

-1.11 (-1.12%)

C Citi
$70.85 /

-0.5 (-0.70%)

Initiation
Biophytis initiated with a Buy at H.C. Wainwright » 06:08
10/25/21
10/25
06:08
10/25/21
06:08
BPTS

Biophytis

$6.05 /

-0.2 (-3.20%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Joseph Pantginis initiated coverage of Biophytis with a Buy rating and $15 price target. Biophytis has built out an "intriguing portfolio" of therapeutics based on phytochemicals, or compounds derived from plants, Pantginis tells investors in a research note. He believes the shares should be attractive to investors based on potential commercialization of Sarconeos for Covid-19 on the horizon and upcoming clinical milestones across multiple programs.

ShowHide Related Items >><<
BPTS Biophytis
$6.05 /

-0.2 (-3.20%)

BPTS Biophytis
$6.05 /

-0.2 (-3.20%)

  • 10
    Feb
BPTS Biophytis
$6.05 /

-0.2 (-3.20%)

Friday
Hot Stocks
'GTA: The Trilogy' out for Switch, PS4, PS5, Xbox consoles on November 11 » 10:21
10/22/21
10/22
10:21
10/22/21
10:21
TTWO

Take-Two

$179.04 /

-3.24 (-1.78%)

, SONY

Sony

$112.77 /

+0.46 (+0.41%)

, MSFT

Microsoft

$310.19 /

-0.51 (-0.16%)

, NTDOY

Nintendo

$54.69 /

-0.04 (-0.07%)

Take-Two's (TTWO)…

Take-Two's (TTWO) Rockstar Games confirmed that "Grand Theft Auto: The Trilogy - The Definitive Edition," a collection of remastered games in the "GTA" series, will launch on November 11, 2021 for PC, PlayStation 4 (SONY), PS5, Xbox One (MSFT), Xbox Series X/S, and Nintendo Switch (NTDOY). The collection will be priced at $59.99. Reference Link

ShowHide Related Items >><<
TTWO Take-Two
$179.04 /

-3.24 (-1.78%)

SONY Sony
$112.77 /

+0.46 (+0.41%)

NTDOY Nintendo
$54.69 /

-0.04 (-0.07%)

MSFT Microsoft
$310.19 /

-0.51 (-0.16%)

TTWO Take-Two
$179.04 /

-3.24 (-1.78%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 BMO Capital
Take-Two downgraded to Market Perform from Outperform at BMO Capital
09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
SONY Sony
$112.77 /

+0.46 (+0.41%)

09/27/21 Cowen
Sony initiated with an Outperform at Cowen
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
07/27/21 Morgan Stanley
Sony upgraded to Overweight at Morgan Stanley on animation business growth
07/27/21 Morgan Stanley
Sony upgraded to Overweight from Equal Weight at Morgan Stanley
MSFT Microsoft
$310.19 /

-0.51 (-0.16%)

10/21/21 Citi
Microsoft price target lowered to $384 from $411 at Citi
10/20/21 Barclays
Zoom Video initiated with an Equal Weight at Barclays
10/20/21 Barclays
RingCentral initiated with an Overweight at Barclays
10/20/21 Wedbush
Microsoft price target raised to $375 from $350 at Wedbush
NTDOY Nintendo
$54.69 /

-0.04 (-0.07%)

10/01/21 DZ Bank
Nintendo downgraded to Hold from Buy at DZ Bank
08/02/21 Wedbush
Nintendo selloff may be overdone if OLED, Pokemon deliver, says Wedbush
07/07/21 Jefferies
Jefferies downgrades Nintendo to Hold with only 7% upside seen
07/06/21 Jefferies
Nintendo downgraded to Hold from Buy at Jefferies
TTWO Take-Two
$179.04 /

-3.24 (-1.78%)

SONY Sony
$112.77 /

+0.46 (+0.41%)

NTDOY Nintendo
$54.69 /

-0.04 (-0.07%)

MSFT Microsoft
$310.19 /

-0.51 (-0.16%)

TTWO Take-Two
$179.04 /

-3.24 (-1.78%)

SONY Sony
$112.77 /

+0.46 (+0.41%)

NTDOY Nintendo
$54.69 /

-0.04 (-0.07%)

MSFT Microsoft
$310.19 /

-0.51 (-0.16%)

TTWO Take-Two
$179.04 /

-3.24 (-1.78%)

SONY Sony
$112.77 /

+0.46 (+0.41%)

NTDOY Nintendo
$54.69 /

-0.04 (-0.07%)

MSFT Microsoft
$310.19 /

-0.51 (-0.16%)

TTWO Take-Two
$179.04 /

-3.24 (-1.78%)

SONY Sony
$112.77 /

+0.46 (+0.41%)

MSFT Microsoft
$310.19 /

-0.51 (-0.16%)

Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call » 10:03
10/22/21
10/22
10:03
10/22/21
10:03
ATVI

Activision Blizzard

$79.26 /

+0.53 (+0.67%)

, EA

Electronic Arts

$141.76 /

+1.16 (+0.83%)

, GME

GameStop

$175.50 /

-6.56 (-3.60%)

, NTDOY

Nintendo

$54.69 /

-0.04 (-0.07%)

, TTWO

Take-Two

$179.90 /

-2.38 (-1.31%)

, UBSFY

Ubisoft

$11.04 /

+0.125 (+1.15%)

Digital Media Analyst…

Digital Media Analyst Pachter provides a monthly review and update for the Video Game Industry on an Analyst/Industry conference call to be held on November 1 at 10:30 am.

ShowHide Related Items >><<
UBSFY Ubisoft
$11.04 /

+0.125 (+1.15%)

TTWO Take-Two
$179.90 /

-2.38 (-1.31%)

NTDOY Nintendo
$54.69 /

-0.04 (-0.07%)

GME GameStop
$175.50 /

-6.56 (-3.60%)

EA Electronic Arts
$141.76 /

+1.16 (+0.83%)

ATVI Activision Blizzard
$79.26 /

+0.53 (+0.67%)

ATVI Activision Blizzard
$79.26 /

+0.53 (+0.67%)

10/21/21 Oppenheimer
Activision Blizzard price target lowered to $100 from $105 at Oppenheimer
09/29/21 Jefferies
Jefferies still bullish on Activision Blizzard after analyzing 72 scenarios
09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
EA Electronic Arts
$141.76 /

+1.16 (+0.83%)

09/15/21 Raymond James
Delay of EA's Battlefield 2042 likely a 'mild negative,' says Raymond James
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
GME GameStop
$175.50 /

-6.56 (-3.60%)

09/27/21 Ascendiant
Ascendiant keeps Sell rating on GameStop, cuts price target to $24
07/12/21 Ascendiant
GameStop price target raised to $25 from $10 at Ascendiant
06/28/21 Baird
Baird suspends GameStop rating pending business strategy clarity
06/10/21 Wedbush
GameStop price target raised to $50 from $39 at Wedbush
NTDOY Nintendo
$54.69 /

-0.04 (-0.07%)

10/01/21 DZ Bank
Nintendo downgraded to Hold from Buy at DZ Bank
08/02/21 Wedbush
Nintendo selloff may be overdone if OLED, Pokemon deliver, says Wedbush
07/07/21 Jefferies
Jefferies downgrades Nintendo to Hold with only 7% upside seen
07/06/21 Jefferies
Nintendo downgraded to Hold from Buy at Jefferies
TTWO Take-Two
$179.90 /

-2.38 (-1.31%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 BMO Capital
Take-Two downgraded to Market Perform from Outperform at BMO Capital
09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
UBSFY Ubisoft
$11.04 /

+0.125 (+1.15%)

10/22/21 Jefferies
Ubisoft upgraded to Buy from Hold at Jefferies
10/20/21 Berenberg
Ubisoft price target lowered to EUR 72 from EUR 74 at Berenberg
10/14/21 JPMorgan
Ubisoft price target lowered to EUR 70 from EUR 84 at JPMorgan
10/14/21 JPMorgan
Ubisoft placed on 'negative Catalyst Watch' at JPMorgan
UBSFY Ubisoft
$11.04 /

+0.125 (+1.15%)

TTWO Take-Two
$179.90 /

-2.38 (-1.31%)

NTDOY Nintendo
$54.69 /

-0.04 (-0.07%)

GME GameStop
$175.50 /

-6.56 (-3.60%)

EA Electronic Arts
$141.76 /

+1.16 (+0.83%)

ATVI Activision Blizzard
$79.26 /

+0.53 (+0.67%)

UBSFY Ubisoft
$11.04 /

+0.125 (+1.15%)

TTWO Take-Two
$179.90 /

-2.38 (-1.31%)

NTDOY Nintendo
$54.69 /

-0.04 (-0.07%)

GME GameStop
$175.50 /

-6.56 (-3.60%)

EA Electronic Arts
$141.76 /

+1.16 (+0.83%)

ATVI Activision Blizzard
$79.26 /

+0.53 (+0.67%)

TTWO Take-Two
$179.90 /

-2.38 (-1.31%)

NTDOY Nintendo
$54.69 /

-0.04 (-0.07%)

GME GameStop
$175.50 /

-6.56 (-3.60%)

EA Electronic Arts
$141.76 /

+1.16 (+0.83%)

ATVI Activision Blizzard
$79.26 /

+0.53 (+0.67%)

TTWO Take-Two
$179.90 /

-2.38 (-1.31%)

GME GameStop
$175.50 /

-6.56 (-3.60%)

EA Electronic Arts
$141.76 /

+1.16 (+0.83%)

ATVI Activision Blizzard
$79.26 /

+0.53 (+0.67%)

Options
Largest borrow rate increases among liquid names » 08:45
10/22/21
10/22
08:45
10/22/21
08:45
DNA

Ginkgo Bioworks

$13.20 /

-0.55 (-4.00%)

, HOOD

Robinhood

$41.25 /

-0.57 (-1.36%)

, SKIN

Beauty Health

$27.22 /

+0.24 (+0.89%)

, RKLB

Rocket Lab

$12.66 /

-0.07 (-0.55%)

, CIFR

Cipher Mining

$8.33 /

-0.41 (-4.69%)

, OPAD

Offerpad Solutions

$7.77 /

-0.415 (-5.07%)

, MVST

Microvast

$8.10 /

-0.005 (-0.06%)

, SPIR

Spire Global

$5.68 /

-0.05 (-0.87%)

, LICY

Li-Cycle

$11.40 /

-0.255 (-2.19%)

, DOLE

Dole

$15.44 /

+0.09 (+0.59%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: (DNA) 162.59% +53.05, Robinhood Markets (HOOD) 179.03% +12.42, Beauth Health Company (SKIN) 11.00% +10.67, Rocket Lab USA (RKLB) 46.22% +9.10, (CIFR) 145.69% +4.39, (OPAD) 69.10% +2.42, Microvast Holdings (MVST) 120.00% +2.02, Spire Global (SPIR) 65.92% +1.39, Li Cycle Holdings Corp (LICY) 29.86% +1.02, and (DOLE) 1.38% +0.50.

ShowHide Related Items >><<
SPIR Spire Global
$5.68 /

-0.05 (-0.87%)

SKIN Beauty Health
$27.22 /

+0.24 (+0.89%)

RKLB Rocket Lab
$12.66 /

-0.07 (-0.55%)

OPAD Offerpad Solutions
$7.77 /

-0.415 (-5.07%)

MVST Microvast
$8.10 /

-0.005 (-0.06%)

LICY Li-Cycle
$11.40 /

-0.255 (-2.19%)

HOOD Robinhood
$41.25 /

-0.57 (-1.36%)

DOLE Dole
$15.44 /

+0.09 (+0.59%)

DNA Ginkgo Bioworks
$13.20 /

-0.55 (-4.00%)

CIFR Cipher Mining
$8.33 /

-0.41 (-4.69%)

DNA Ginkgo Bioworks
$13.20 /

-0.55 (-4.00%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HOOD Robinhood
$41.25 /

-0.57 (-1.36%)

10/22/21 JPMorgan
Robinhood shares 'vulnerable' with liquidity coming, says JPMorgan
10/05/21 Mizuho
Most Robinhood users would pay small fee to stay on platform, says Mizuho
08/23/21
Fly Intel: Top five analyst initiations
08/23/21 Rosenblatt
Robinhood initiated with a Buy at Rosenblatt
SKIN Beauty Health
$27.22 /

+0.24 (+0.89%)

10/07/21 Stifel
Beauty Health initiated with a Buy at Stifel
10/04/21 Cowen
Cowen sees Beauty Health as category leader, starts with Outperform
10/04/21 Cowen
Beauty Health initiated with an Outperform at Cowen
09/20/21 Piper Sandler
Beauty Health could have 'robust year' in 2022, says Piper Sandler
RKLB Rocket Lab
$12.66 /

-0.07 (-0.55%)

10/04/21 BofA
Astra initiated with an Underperform at BofA
09/30/21 Stifel
Rocket Lab initiated with a Buy at Stifel
09/17/21 Deutsche Bank
Rocket Lab initiated with a Buy at Deutsche Bank
09/13/21 Cowen
Rocket Lab USA initiated with a Market Perform at Cowen
CIFR Cipher Mining
$8.33 /

-0.41 (-4.69%)

OPAD Offerpad Solutions
$7.77 /

-0.415 (-5.07%)

10/14/21 JMP Securities
Offerpad Solutions initiated with an Outperform at JMP Securities
09/27/21 Jefferies
Offerpad Solutions initiated with a Hold at Jefferies
MVST Microvast
$8.10 /

-0.005 (-0.06%)

08/03/21 Morgan Stanley
Microvast initiated with an Underweight at Morgan Stanley
SPIR Spire Global
$5.68 /

-0.05 (-0.87%)

10/14/21 Piper Sandler
Spire Global initiated with a Neutral at Piper Sandler
09/08/21 Baird
Baird starts Spire at Neutral, taking 'wait and see approach'
09/08/21 Baird
Spire Corporation initiated with a Neutral at Baird
LICY Li-Cycle
$11.40 /

-0.255 (-2.19%)

10/18/21 Citi
Li-Cycle initiated with a Buy at Citi
09/22/21 UBS
Li-Cycle initiated with a Buy at UBS
09/20/21 Wedbush
Li-Cycle initiated with an Outperform at Wedbush
09/13/21 Morgan Stanley
Li-Cycle initiated with an Overweight at Morgan Stanley
DOLE Dole
$15.44 /

+0.09 (+0.59%)

08/24/21
Fly Intel: Top five analyst initiations
08/24/21 BofA
BofA starts Dole at Underperform, says stock 'not ripe enough'
08/24/21 Stephens
Dole initiated with an Overweight at Stephens
08/24/21 Stephens
Dole initiated with an Overweight at Stephens
SKIN Beauty Health
$27.22 /

+0.24 (+0.89%)

RKLB Rocket Lab
$12.66 /

-0.07 (-0.55%)

MVST Microvast
$8.10 /

-0.005 (-0.06%)

LICY Li-Cycle
$11.40 /

-0.255 (-2.19%)

HOOD Robinhood
$41.25 /

-0.57 (-1.36%)

  • 30
    Jul
  • 29
    Jul
RKLB Rocket Lab
$12.66 /

-0.07 (-0.55%)

HOOD Robinhood
$41.25 /

-0.57 (-1.36%)

DOLE Dole
$15.44 /

+0.09 (+0.59%)

DNA Ginkgo Bioworks
$13.20 /

-0.55 (-4.00%)

SKIN Beauty Health
$27.22 /

+0.24 (+0.89%)

RKLB Rocket Lab
$12.66 /

-0.07 (-0.55%)

OPAD Offerpad Solutions
$7.77 /

-0.415 (-5.07%)

MVST Microvast
$8.10 /

-0.005 (-0.06%)

LICY Li-Cycle
$11.40 /

-0.255 (-2.19%)

HOOD Robinhood
$41.25 /

-0.57 (-1.36%)

DOLE Dole
$15.44 /

+0.09 (+0.59%)

DNA Ginkgo Bioworks
$13.20 /

-0.55 (-4.00%)

SPIR Spire Global
$5.68 /

-0.05 (-0.87%)

SKIN Beauty Health
$27.22 /

+0.24 (+0.89%)

RKLB Rocket Lab
$12.66 /

-0.07 (-0.55%)

OPAD Offerpad Solutions
$7.77 /

-0.415 (-5.07%)

MVST Microvast
$8.10 /

-0.005 (-0.06%)

LICY Li-Cycle
$11.40 /

-0.255 (-2.19%)

HOOD Robinhood
$41.25 /

-0.57 (-1.36%)

DOLE Dole
$15.44 /

+0.09 (+0.59%)

DNA Ginkgo Bioworks
$13.20 /

-0.55 (-4.00%)

CIFR Cipher Mining
$8.33 /

-0.41 (-4.69%)

Upgrade
Invesco upgraded to In Line amid Evercore ISI rating 'reshufflng » 08:08
10/22/21
10/22
08:08
10/22/21
08:08
IVZ

Invesco

$25.02 /

-0.39 (-1.54%)

Evercore ISI analyst…

Evercore ISI analyst Glenn Schorr upgraded Invesco to In Line from Underperform with an unchanged price target of $28 as he does "a little reshuffling" of his ratings in the financials space. He is feeling better about the durability of Invesco's organic growth and improving profitability, citing recent growth in ETFs, alternatives, active fixed income, global equities, SMAs and the onshore business in China, Schorr tells investors.

ShowHide Related Items >><<
IVZ Invesco
$25.02 /

-0.39 (-1.54%)

IVZ Invesco
$25.02 /

-0.39 (-1.54%)

10/22/21 Evercore ISI
Invesco upgraded to In Line from Underperform at Evercore ISI
09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
07/12/21 Deutsche Bank
Invesco price target raised to $35 from $33 at Deutsche Bank
IVZ Invesco
$25.02 /

-0.39 (-1.54%)

IVZ Invesco
$25.02 /

-0.39 (-1.54%)

IVZ Invesco
$25.02 /

-0.39 (-1.54%)

IVZ Invesco
$25.02 /

-0.39 (-1.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.